期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
TRIM27 maintains gut homeostasis by promoting intestinal stem cell self-renewal 被引量:2
1
作者 Jing Wang Dongdong Zhao +11 位作者 Zehui Lei Pupu Ge Zhe Lu qiyao chai Yong Zhang Lihua Qiang Yang Yu Xinwen Zhang Bingxi Li Shu Zhu Lingqiang Zhang Cui Hua Liu 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2023年第2期158-174,共17页
Dysregulation of gut homeostasis is associated with irritable bowel syndrome(IBS),a chronic functional gastrointestinal disorder affecting approximately 11.2%of the global population.The poorly understood pathogenesis... Dysregulation of gut homeostasis is associated with irritable bowel syndrome(IBS),a chronic functional gastrointestinal disorder affecting approximately 11.2%of the global population.The poorly understood pathogenesis of IBS has impeded its treatment.Here,we report that the E3 ubiquitin ligase tripartite motif-containing 27(TRIM27)is weakly expressed in IBS but highly expressed in inflammatory bowel disease(IBD),a frequent chronic organic gastrointestinal disorder.Accordingly,knockout of Trim27 in mice causes spontaneously occurring IBS-like symptoms,including increased visceral hyperalgesia and abnormal stool features,as observed in IBS patients.Mechanistically,TRIM27 stabilizesβ-catenin and thus activates Wnt/β-catenin signaling to promote intestinal stem cell(ISC)self-renewal.Consistent with these findings,Trim27 deficiency disrupts organoid formation,which is rescued by reintroducing TRIM27 orβ-catenin.Furthermore,Wnt/β-catenin signaling activator treatment ameliorates IBS symptoms by promoting ISC self-renewal.Taken together,these data indicate that TRIM27 is critical for maintaining gut homeostasis,suggesting that targeting the TRIM27/Wnt/β-catenin axis could be a potential treatment strategy for IBS.Our study also indicates that TRIM27 might serve as a potential biomarker for differentiating IBS from IBD. 展开更多
关键词 TRIM27 Wnt/β-catenin signaling ISC self-renewal IBS
原文传递
Mycobacterium tuberculosis Mce2E suppresses the macrophage innate immune response and promotes epithelial cell proliferation 被引量:7
2
作者 Lihua Qiang Jing Wang +7 位作者 Yong Zhang Pupu Ge qiyao chai Bingxi Li Yi Shi Lingqiang Zhang George Fu Gao Cui Hua Liu 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2019年第4期380-391,共12页
The intracellular pathogen Mycobacterium tuberculosis(Mtb)can survive in the host and cause disease by interfering with a variety of cellular functions.The mammalian cell entry 2(mce2)operon of Mtb has been shown to c... The intracellular pathogen Mycobacterium tuberculosis(Mtb)can survive in the host and cause disease by interfering with a variety of cellular functions.The mammalian cell entry 2(mce2)operon of Mtb has been shown to contribute to tuberculosis pathogenicity.However,little is known about the regulatory roles of Mtb Mce2 family proteins towards host cellular functions.Here we show that the Mce2 family protein Mce2E suppressed the macrophage innate immune response and promoted epithelial cell proliferation.Mce2E inhibited activation of the extracellular signal-regulated kinase(ERK)and Jun N-terminal kinase(JNK)mitogen-activated protein kinase(MAPK)signaling pathways in a non-canonical D motif(a MAPK-docking motif)-dependent manner,leading to reduced expression of TNF and IL-6 in macrophages.Furthermore,Mce2E promoted proliferation of human lung epithelium-derived lung adenoma A549 cells by inhibiting K48-linked polyubiquitination of eEF1A1 in aβstrand region-dependent manner.In summary,Mce2E is a novel multifunctional Mtb virulence factor that regulates host cellular functions in a niche-dependent manner.Our data suggest a potential novel target for TB therapy. 展开更多
关键词 Mycobacterium tuberculosis Mce2E innate immune response cell proliferation
原文传递
病原菌利用磷脂磷酸酶挟持宿主泛素并抑制细胞焦亡的免疫逃逸机制
3
作者 柴琪瑶 刘翠华 《科学通报》 EI CAS CSCD 北大核心 2022年第36期4309-4311,共3页
结核病(tuberculosis)是一种由结核分枝杆菌(Mycobacterium tuberculosis)感染引起的古老的传染性疾病,目前依旧严重威胁全球人类健康.据世界卫生组织(World Health Organization,WHO)报道,2020年全球约有987万结核新发病例,并有149.8... 结核病(tuberculosis)是一种由结核分枝杆菌(Mycobacterium tuberculosis)感染引起的古老的传染性疾病,目前依旧严重威胁全球人类健康.据世界卫生组织(World Health Organization,WHO)报道,2020年全球约有987万结核新发病例,并有149.8万人死于结核感染.此外,研究显示,全球敏感结核病治疗成功率为85%,而耐多药/耐利福平药结核(MDR/RR-TB)的治疗成功率仅为57%[1]. 展开更多
关键词 结核病治疗 结核感染 细胞焦亡 耐多药 免疫逃逸机制 新发病例 磷酸酶 传染性疾病
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部